Schafer Cullen Capital Management’s Merck MRK Stock Holding History

Schafer Cullen Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$8.42M	Sell	114,499 -1,444,664	-93%	-$107M	1.72%	29
2020 Q4	$122M	Sell	1,559,163 -127,493	-8%	-$9.75M	1.8%	17
2020 Q3	$134M	Sell	1,686,656 -80,500	-5%	-$6.31M	2.1%	12
2020 Q2	$130M	Sell	1,767,156 -116,540	-6%	-$8.77M	2.01%	16
2020 Q1	$138M	Sell	1,883,696 -118,789	-6%	-$9.34M	2.32%	11
2019 Q4	$174M	Sell	2,002,485 -431,538	-18%	-$35.4M	2.04%	20
2019 Q3	$196M	Sell	2,434,023 -57,099	-2%	-$4.58M	2.36%	9
2019 Q2	$190M	Buy	2,491,122 +468,172	+23%	+$35.8M	2.23%	11
2019 Q1	$161M	Sell	2,022,950 -87,225	-4%	-$6.52M	2.35%	6
2018 Q4	$154M	Sell	2,110,175 -75,939	-3%	-$5.36M	2.37%	4
2018 Q3	$148M	Sell	2,186,114 -76,147	-3%	-$4.85M	1.92%	16
2018 Q2	$131M	Sell	2,262,261 -187,804	-8%	-$10.6M	1.69%	19
2018 Q1	$127M	Buy	2,450,065 +158,129	+7%	+$8.54M	1.53%	23
2017 Q4	$123M	Sell	2,291,936 -62,893	-3%	-$3.49M	1.43%	26
2017 Q3	$144M	Buy	2,354,829 +68,463	+3%	+$4.15M	1.73%	18
2017 Q2	$140M	Sell	2,286,366 -63,926	-3%	-$3.89M	1.74%	18
2017 Q1	$142M	Sell	2,350,292 -42,799	-2%	-$2.6M	1.83%	15
2016 Q4	$134M	Sell	2,393,091 -401,184	-14%	-$23.5M	1.82%	16
2016 Q3	$166M	Sell	2,794,275 -85,664	-3%	-$5.01M	2%	9
2016 Q2	$158M	Sell	2,879,939 -98,563	-3%	-$5.25M	1.92%	16
2016 Q1	$150M	Sell	2,978,502 -30,467	-1%	-$1.49M	1.84%	16
2015 Q4	$152M	Sell	3,008,969 -220,225	-7%	-$11.1M	1.8%	13
2015 Q3	$152M	Sell	3,229,194 -633,407	-16%	-$33.6M	1.75%	15
2015 Q2	$210M	Sell	3,862,601 -234,882	-6%	-$13.2M	2.17%	4
2015 Q1	$225M	Buy	4,097,483 +497,765	+14%	+$28.2M	2.23%	2
2014 Q4	$195M	Sell	3,599,718 -621,967	-15%	-$34.7M	2.47%	6
2014 Q3	$239M	Sell	4,221,685 -118,085	-3%	-$6.63M	2.28%	4
2014 Q2	$240M	Sell	4,339,770 -131,082	-3%	-$7.15M	2.21%	6
2014 Q1	$242M	Sell	4,470,852 -100,861	-2%	-$5.22M	2.35%	4
2013 Q4	$218M	Buy	4,571,713 +64,215	+1%	+$2.94M	2.16%	8
2013 Q3	$205M	Sell	4,507,498 -18,812	-0.4%	-$859K	2.25%	8
2013 Q2	$201M	Buy	+4,526,310	New	+$202M	2.4%	6

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schafer Cullen Capital Management's MRK Position: Q1 2021 in Review

Schafer Cullen Capital Management reduced its Merck (MRK) stake by 93% in Q1 2021, selling an estimated $107M and leaving 114,499 shares worth $8.42M. The position accounts for 1.72% of the portfolio, ranked #29.

Schafer Cullen Capital Management first reported a position in MRK in Q2 2013 and has held it in 32 quarters since. The position peaked at $242M in Q1 2014. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

Schafer Cullen Capital Management held 114,499 shares of Merck worth $8.42M as of Q1 2021.
Schafer Cullen Capital Management sold 1,444,664 Merck shares in Q1 2021, an estimated $107M.
Merck made up 1.72% of Schafer Cullen Capital Management's portfolio in Q1 2021, its #29 holding.
Schafer Cullen Capital Management first reported a position in Merck in Q2 2013 and has held it in 32 quarters since.
Schafer Cullen Capital Management's Merck position peaked at $242M in Q1 2014.
2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.